Cite
HARVARD Citation
Deijen, C. et al. (n.d.). PO-1182: PSMA-PET is superior to choline-PET based SABR for ADT deferral in oligometastatic prostate cancer. Radiotherapy and oncology. pp. S622-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Deijen, C. et al. (n.d.). PO-1182: PSMA-PET is superior to choline-PET based SABR for ADT deferral in oligometastatic prostate cancer. Radiotherapy and oncology. pp. S622-. [Online].